Wilmington Trust Investment Management’s Pfizer PFE Stock Holding History

Wilmington Trust Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$1.59M	Sell	56,389 -10,418	-16%	-$297K	0.32%	52
2014 Q1	$2.04M	Sell	66,807 -58,960	-47%	-$1.76M	0.41%	42
2013 Q4	$3.65M	Sell	125,767 -4,349	-3%	-$127K	0.73%	15
2013 Q3	$3.54M	Sell	130,116 -14,801	-10%	-$403K	0.74%	19
2013 Q2	$3.85M	Buy	+144,917	New	+$4M	0.83%	17

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wilmington Trust Investment Management's PFE Position: Q2 2014 in Review

Wilmington Trust Investment Management reduced its Pfizer (PFE) stake by 16% in Q2 2014, selling an estimated $297K and leaving 56,389 shares worth $1.59M. The position accounts for 0.32% of the portfolio, ranked #52.

Wilmington Trust Investment Management first reported a position in PFE in Q2 2013 and has held it in 5 quarters since. The position peaked at $3.85M in Q2 2013. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

Wilmington Trust Investment Management held 56,389 shares of Pfizer worth $1.59M as of Q2 2014.
Wilmington Trust Investment Management sold 10,418 Pfizer shares in Q2 2014, an estimated $297K.
Pfizer made up 0.32% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #52 holding.
Wilmington Trust Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 5 quarters since.
Wilmington Trust Investment Management's Pfizer position peaked at $3.85M in Q2 2013.
1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.